Document is current
Any future updates will be listed below
-
Authors
Fadini, Gian Paolo https://orcid.org/0000-0002-6510-2097
Ciardullo, Stefano
Perseghin, Gianluca
Giordano, Carla
Maddaloni, Ernesto
Buzzetti, Raffaella
Ghiani, Mariangela
Avogaro, Angelo
-
Funding
Funding for this research was provided by:
Società Italiana di Diabetologia
Novo Nordisk
- License Information
-
More Information
Article History
Received: 8 January 2025
Accepted: 12 March 2025
First Online: 28 March 2025
Declarations
:
: Gian Paolo Fadini received honoraria for lectures, consultancy or advisory board from Abbott, AstraZeneca, Boehringer, Guidotti, Lilly, Mundipharma, Novartis, Novo Nordisk, Sanofi, Servier, Takeda. Stefano Ciardullo received honoraria for lectures from AstraZeneca, Boehringer Ingelheim, Guidotti, Eli Lilly, Novo Nordisk, MSD. Gianluca Perseghin received honoraria for lectures: AstraZeneca, Bayer, Boheringer Ingelheim, Daiichi Sankyo, Echosens, Lilly, Menarini Diag, Merck, Novo Nordisk, Pfizer, PikDare; received honoraria for advisory bord: Amgen, Bruno Farmaceutici, EG, Lilly, Merck, Novartis, Novo Nordisk, Pfizer, PikDare. Ernesto Maddaloni reports consulting fees, payment or honoraria for lectures, presentations or advisory boards from Abbott, AstraZeneca, Eli Lilly, MSD, MTD, NovoNordisk, PikDare. Raffaella Buzzetti reports research grants from AstraZeneca and speaker/consultancy fees from Eli Lilly, Sanofi, Abbott, Vertex, NovoNordisk, Boehringer Ingheleim, AstraZeneca, Mundipharma, and Guidotti. Angelo Avogaro received honoraria for lectures, consultancy or advisory board from AstraZeneca, Boehringer, Guidotti, Lilly, Novo Nordisk, Sanofi, Servier, Menarini. Carla Giordano and Mariangela Ghiani have nothing to declare. Gian Paolo Fadini is an Editorial Board member of Diabetes Therapy. Gian Paolo Fadini was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.
: The activity complied with the principles of the Declaration of Helsinki and was performed outside of the National Healthcare System (NHS) and no NHS data or resources were used. Participants provided digital informed consent to the use of data collected anonymously during the questionnaire-based interview for the scope of this project. On the basis of these premises, considering this was not a clinical trial or a clinical study, according the national and European regulations on data protection, need for an ethical approval was waived.
